Australia Seeks To Join Apotex In Suit Against Sanofi For Delaying Generic
This article was originally published in PharmAsia News
Executive Summary
The Australian government has filed to join an Apotex suit against Sanofi, claiming the France-based company delayed generics of its Plavix (clopidogrel) anticoagulant from the market, costing the treasury more than $130 million a year.